Steris Plc has been the focus of multiple transactions and analyst recommendations as seen in the recent series of market activity. It has been witnessed that many investment firms including
Asset Management One Co. Ltd., Harvey Investment Co. LLC, Ethic Inc., Fenimore Asset Management Inc., Cwm LLC, and others are either buying, raising their positions, or selling their stake in
Steris Plc. Several companies such as
Harbor Capital Advisors Inc., Foster Victor Wealth Advisors LLC, Addenda Capital Inc., and more have even initiated or increased their positions in the company. With strong Q2 2026 earnings that featured improved margins and robust revenue growth, the sentiment towards Steris Plc remains largely bullish. However, it should not be overlooked that certain entities like Copeland Capital Management LLC, London Co. of Virginia, among others, have reduced their stake, indicating a mix of market opinions.
Steris Plc has also received an average recommendation of 'Moderate Buy' from Wall Street analysts. Strong Q2 results and reaffirmed revenue guidance have led to stock gains. Steris Plc CEO also sold shares worth $38,449. The stock has been closely matching trends in the healthcare sector and S&P 500.
Steris Plc STE News Analytics from Thu, 06 Dec 2018 08:00:00 GMT to Sat, 10 Jan 2026 18:21:09 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor 1
